CA Patent
CA2082398C — Surgical implant and method incorporating chemotherapeutic agents
Assigned to Individual · Expires 2004-06-29 · 22y expired
What this patent protects
An implant and method is disclosed using microparticles to provides a controlled, sustained release, and improved cellular uptake, of chemotherapeutic agents.
USPTO Abstract
An implant and method is disclosed using microparticles to provides a controlled, sustained release, and improved cellular uptake, of chemotherapeutic agents.
Drugs covered by this patent
- Solosec (SECNIDAZOLE) · Evofem Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.